Clinical Trials

Published for social benefit, for informational and educational purposes only, not for profit.

November 2020

KAROLINSKA INSTITUTET | Baricitinib treatment linked to reduced mortality in COVID-19 patients | JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

2020-11-15T06:57:07+00:00November 15th, 2020|

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality ABSTRACT. Using AI we identified baricitinib as possessing anti-viral and anti-cytokine efficacy. We now show [...]

October 2020

NATURE | A perspective on potential antibody-dependent enhancement of SARS-CoV-2 [66 References] | Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures – Nature Biotechnology [139 References]

2020-10-21T04:20:18+00:00October 21st, 2020|

A perspective on potential antibody-dependent enhancement of SARS-CoV-2 - Nature SEE BELOW Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures - Nature Biotechnology Reprinted for educational purposes and social [...]

ClinicalTrials.gov | SARS-CoV-2 Vaccines

2020-10-06T07:28:39+00:00October 5th, 2020|

COVID, SARS-CoV-2, Vaccine: 254 Studies as of 5 October 2020 Download PDF (First 100) Download Zip for all 254 Studies Protein Subunit Vaccine Example Evaluation of the Safety and Immunogenicity [...]